• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

8p11.2 染色体易位:在单机构连续队列的 13 例病例中,FGFR1 和 MYST3 的 FISH 分析及其与临床病理的相关性。

Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.

机构信息

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

出版信息

Am J Hematol. 2010 Apr;85(4):238-42. doi: 10.1002/ajh.21631.

DOI:10.1002/ajh.21631
PMID:20143402
Abstract

Chromosome 8p11.2 translocations result in diverse oncogenic fusion genes involving FGFR1 or MYST3. Among 24,262 unique patient cytogenetic studies performed at the Mayo Clinic, 8p11.2 translocations were identified in 14 cases ( approximately 0.06%). FISH analysis was performed in 13 patients (12 had myeloid neoplasms) and revealed abnormalities of MYST3 (n = 4) or FGFR1 (n = 4) in eight patients. MYST3 abnormalities were associated with acute myeloid leukemia (AML), M4 in three and M6 in one. Three of the four FGFR1-rearranged cases were associated with myeloproliferative neoplasms but none, including the two with sole 8p11.2, displayed the typical phenotype for stem cell leukemia/lymphoma (SCLL) and only one had eosinophilia; the fourth case had AML-M4. FISH did not reveal FGFR1 involvement in the one patient with SCLL. We conclude that neither the SCLL phenotype nor blood eosinophilia is a consistent feature of FGFR1-associated 8p11.2 translocations; conversely, FISH might not always reveal FGFR1 involvement in typical SCLL.

摘要

8p11.2 染色体易位导致涉及 FGFR1 或 MYST3 的多种致癌融合基因。在梅奥诊所进行的 24262 项独特的患者细胞遗传学研究中,鉴定出 14 例 8p11.2 易位(约 0.06%)。在 13 例患者中进行了 FISH 分析(12 例患有髓系肿瘤),在 8 例患者中发现了 MYST3(n=4)或 FGFR1(n=4)异常。MYST3 异常与急性髓系白血病(AML)相关,其中 3 例为 M4,1 例为 M6。4 例 FGFR1 重排病例中有 3 例与骨髓增生性肿瘤相关,但没有一例(包括 2 例仅有 8p11.2 的病例)显示出干细胞白血病/淋巴瘤(SCLL)的典型表型,仅有 1 例存在嗜酸性粒细胞增多症;第 4 例为 AML-M4。FISH 未显示出 SCLL 患者中有 FGFR1 参与。我们得出结论,既不是 SCLL 表型,也不是血液嗜酸性粒细胞增多症是 FGFR1 相关 8p11.2 易位的一致特征;相反,FISH 可能并不总是揭示典型 SCLL 中 FGFR1 的参与。

相似文献

1
Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.8p11.2 染色体易位:在单机构连续队列的 13 例病例中,FGFR1 和 MYST3 的 FISH 分析及其与临床病理的相关性。
Am J Hematol. 2010 Apr;85(4):238-42. doi: 10.1002/ajh.21631.
2
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.日本九家机构连续队列研究中染色体 8p11.2 易位的发生率及其与 FGFR1 异常相关的髓系和淋巴系肿瘤的相关性。
Int J Hematol. 2024 Jun;119(6):722-727. doi: 10.1007/s12185-024-03740-0. Epub 2024 Mar 8.
3
8p11 myeloproliferative syndrome: a review.8p11 骨髓增生性综合征:综述。
Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003.
4
Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.一名婴儿8p11骨髓增殖综合征的分子监测
J Pediatr Hematol Oncol. 2009 Nov;31(11):879-83. doi: 10.1097/MPH.0b013e3181b83fd0.
5
Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.9p24 染色体异常:发生率、新型 JAK2 易位描述、JAK2V617F 突变分析及临床病理相关性。
Eur J Haematol. 2010 Jun;84(6):518-24. doi: 10.1111/j.1600-0609.2010.01428.x. Epub 2010 Mar 11.
6
Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.具有 PCM1-JAK2 基因融合的血液系统恶性肿瘤具有伴嗜酸性粒细胞增多和 PDGFRA、PDGFRB 和 FGFR1 异常的髓系和淋巴系肿瘤的特征。
Ann Hematol. 2013 Jun;92(6):759-69. doi: 10.1007/s00277-013-1695-3. Epub 2013 Feb 12.
7
t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.与干细胞骨髓增殖性疾病相关的t(6;8)、t(8;9)和t(8;13)易位在染色体区域8p11 - 12具有紧密或相同的断点。
Oncogene. 1998 Feb 19;16(7):945-9. doi: 10.1038/sj.onc.1201601.
8
Identification of four new translocations involving FGFR1 in myeloid disorders.在髓系疾病中鉴定出四种涉及FGFR1的新易位。
Genes Chromosomes Cancer. 2001 Oct;32(2):155-63. doi: 10.1002/gcc.1177.
9
Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.鉴定出一种新型的伙伴基因 TPR,与 8p11 骨髓增生性综合征中的 FGFR1 融合。
Genes Chromosomes Cancer. 2012 Sep;51(9):890-7. doi: 10.1002/gcc.21973. Epub 2012 May 23.
10
Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.伴有t(8;22)(p11.2;q11.2)/BCR-FGFR1的骨髓增殖性肿瘤:20例病例的荟萃分析显示存在B淋巴细胞母细胞期的细胞遗传学进展。
Hum Pathol. 2017 Jul;65:147-156. doi: 10.1016/j.humpath.2017.05.008. Epub 2017 May 24.

引用本文的文献

1
Rapidly progressing after umbilical cord blood transplantation in a boy with acute myeloid leukemia with KAT6A::EP300 fusion transcript.一名患有急性髓系白血病且具有KAT6A::EP300融合转录本的男孩在脐带血移植后病情迅速进展。
Ann Hematol. 2025 Sep 2. doi: 10.1007/s00277-025-06573-x.
2
Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma.培米替尼治疗伴有FGFR1重排、表现为侵袭性B细胞淋巴瘤的髓系/淋系肿瘤。
J Clin Exp Hematop. 2025;65(2):146-152. doi: 10.3960/jslrt.25027.
3
If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide.
如果它是实体瘤靶点,那么它可能是血液系统癌症靶点:弥合巨大差距。
Med. 2025 Jan 10;6(1):100550. doi: 10.1016/j.medj.2024.11.003. Epub 2024 Dec 16.
4
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.日本九家机构连续队列研究中染色体 8p11.2 易位的发生率及其与 FGFR1 异常相关的髓系和淋巴系肿瘤的相关性。
Int J Hematol. 2024 Jun;119(6):722-727. doi: 10.1007/s12185-024-03740-0. Epub 2024 Mar 8.
5
Hematological Neoplasms with Eosinophilia.伴有嗜酸性粒细胞增多的血液系统肿瘤
Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337.
6
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.伴有嗜酸性粒细胞增多和酪氨酸激酶基因融合的髓系/淋巴系肿瘤:基于登记处队列的重新评估定义特征。
Leukemia. 2023 Sep;37(9):1860-1867. doi: 10.1038/s41375-023-01958-1. Epub 2023 Jul 15.
7
A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.FGFR1 激酶的截断衍生物与 FLT3 和 KIT 合作,在综合征和新发 AML 中转化造血干细胞。
Mol Cancer. 2022 Jul 29;21(1):156. doi: 10.1186/s12943-022-01628-3.
8
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.伴有 FGFR1 重排的髓系/淋系肿瘤患者的异基因造血细胞移植:来自 EBMT 慢性恶性肿瘤工作组的研究。
Bone Marrow Transplant. 2022 Mar;57(3):416-422. doi: 10.1038/s41409-021-01553-x. Epub 2022 Jan 23.
9
Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment.FGFR1驱动的白血病和淋巴瘤中对FGFR1抑制剂耐药的机制:对优化治疗的启示
Cancer Drug Resist. 2021;4(3):607-619. doi: 10.20517/cdr.2021.30. Epub 2021 May 25.
10
Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia.重排指导三系B、T和髓系混合表型急性白血病的诊断与治疗。
JCO Precis Oncol. 2020 Aug 25;4. doi: 10.1200/PO.19.00402. eCollection 2020.